Silvia Affò
Research group
- Tumor microenvironment plasticity and heterogeneity (TMHet) Junior group leader (R3B)
About me
After obtaining her PhD in Medicine at University of Barcelona and intrigued by the intersection of liver cancer and fibrosis, in 2014 Dr Silvia Affò moved for her postdoctoral studies to Columbia University, US, where she investigated hepatic stellate cells and cancer-associated fibroblasts. Her work has been published in high impact journals including Cancer Cell, and she has been supported through all the stages of her career by national and international competitive awards and funding, including the prestigious Research Scholar from the American Gastroenterological Association, the competitive La Caixa Junior Leader and Marie Curie, and recently by the ERC Starting Grant 2022
Featured publications
-
Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma
Authors:Reference: Hepatology 2024. -
Fibroblasts in liver cancer: functions and therapeutic translation
Authors:Reference: Lancet Gastroenterology & Hepatology 2023. -
Cholangiocarcinoma - novel biological insights and therapeutic strategies
Authors:Reference: Nature Reviews Clinical Oncology 2023. -
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
Authors:Reference: Nature 2022. -
Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance
Authors:Reference: Advances In Cancer Research 2022. -
The purinergic P2Y14 receptor links hepatocyte death to hepatic stellate cell activation and fibrogenesis in the liver
Authors:Reference: Science Translational Medicine 2022. -
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations
Authors:Reference: Cancer Cell 2021. -
The Role of Cancer-Associated Fibroblasts and Fibrosisin Liver Cancer
Authors:Reference: Annual Review Of Pathology-Mechanisms Of Disease 2017.
Featured Projects
-
Ramon y Cajal competitive Spanish program 2022 in Biomedicine.
Principal investigator: Silvia AffòFunder: Ministerio de Ciencia, Innovación y UniversidadesCode: RYC2022-036321-IDuration: 01/07/2024 - 30/06/2029 -
Deciphering the dynamic-plasticity and heterogeneity of cancer-associated fibroblasts (DynamHet)
Principal investigator: Silvia AffòFunder: European Research Council, European ComissionCode: 101077312Duration: 01/09/2023 - 31/08/2028 -
Investigating the interactions between heterogeneous cancer cells and the tumor microenvironment toward the development of new therapeutic strategies in cholangiocarcinoma (IntHet)
Principal investigator: Silvia AffòFunder: Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de InvestigaciónCode: PID2021-124694OA-100Duration: 01/10/2022 - 30/09/2025